Day One Biopharmaceuticals, Inc. (DAWN)

9.285 +0.10 (+1.14%) USD  |  NASDAQ  |  Dec 31, 10:16
More

Day One Biopharmaceuticals Operating Income (Quarterly YoY Growth)

Operating Income (Quarterly YoY Growth) Chart

View Operating Income (Quarterly YoY Growth) for DAWN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Quarterly YoY Growth) Range, Past 5 Years

View Operating Income (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Quarterly YoY Growth) Benchmarks

View Operating Income (Quarterly YoY Growth) Benchmarks
Start Trial
Mersana Therapeutics, Inc. Upgrade
Iovance Biotherapeutics, Inc. Upgrade
Lantheus Holdings, Inc. Upgrade
iRhythm Technologies, Inc. Upgrade
Perspective Therapeutics, Inc. Upgrade